About this trial
This clinical trial develops and studies whether a restorative justice-based lung cancer screening (LCS) decision-making support intervention tailored for Black individuals increases LCS among Black community members. Lung cancer remains the leading cause of cancer deaths among Black men and women. LCS with yearly low-dose chest computed tomography (CT) is recommended for people with current or recent tobacco use (within 15 years) who are aged 50-80 with at least a 20 pack-year smoking history. LCS lowers lung cancer death by 20%; however, data shows that LCS completion remains low among minority groups in the United States. The restorative justice-based LCS decision-making support intervention in this trial has been specifically tailored to meet the needs of Black individuals. It is designed to reduce racial unfairness by promoting trust, shared understanding, and empowerment in clinical decision making while addressing the social and historical circumstances of health inequalities. This may be an effective way to increase LCS among Black community members.
Eligibility criteria
Qualifiers
Identify as Black or African American
Between ages 50-77
Self-reported 20-pack year smoking history
Ongoing commercial tobacco use within the past 15 years
Disqualifiers
Has a documented chest CT within the past one year
Personal history of lung cancer or symptoms associated with lung cancer
Trial design
Treatments tested in this trial
- Educational Intervention
- Survey Administration
- Interview
- Electronic Health Record Review